[Calmodulin in osteogenic sarcoma].
Kushlinskií
N E
NE
Scientific Oncology Center of NN Blokhin RAMN, Moscow.
Trapeznikov
N N
NN
Sergeev
P V
PV
Solov'ev
I N
IN
Shikhammedov
M D
MD
Babkina
I B
IB
Chukaev
S A
SA
Kasumov
C M
CM
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001859:Bone Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000401:mortality; D002147:Calmodulin / Q000187:drug effects / Q000378:metabolism*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000175:diagnosis; D012516:Osteosarcoma / Q000188:drug therapy / Q000378:metabolism* / Q000401:mortality; D011379:Prognosis; D011863:Radioimmunoassay; D015996:Survival Rate
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D002147:Calmodulin